Source:http://linkedlifedata.com/resource/pubmed/id/10424444
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1999-9-16
|
pubmed:abstractText |
The CD56+CD16+ natural killer (NK) cell population plays a crucial role in eliminating virus-infected cells and is diminished in HIV-infected individuals. This study examined the effects of exogenous interleukin (IL)-15 on proliferation and survival of CD56+ and CD16+ cells of HIV-infected individuals. When used at equivalent concentrations in vitro, IL-15 was more potent than IL-2 as a growth factor for CD56+ cells, as well as for CD16+ cells and also CD4+ and CD8+ T cells. Analysis of cell survival in etoposide-treated cultures indicated that IL-15 was also more potent than IL-2 as a survival factor for CD56+ cells by virtue of its greater ability to up-regulate bcl-2 expression. Although IL-15-induced proliferation of CD56+ cells was accompanied by increased apoptosis, IL-15 was more effective than IL-2 in increasing the representation of viable CD56+ cells in the peripheral blood mononuclear cell population, but less effective in increasing T cell representation. The immunotherapeutic potential of IL-15 appears superior to IL-2 in regard to expanding NK cell populations in HIV-infected individuals, but needs to be weighed against poorer increases in T cell populations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD56,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/CD69 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, IgG
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0165-2478
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359-67
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10424444-Antigens, CD,
pubmed-meshheading:10424444-Antigens, CD56,
pubmed-meshheading:10424444-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:10424444-Cell Division,
pubmed-meshheading:10424444-Cell Survival,
pubmed-meshheading:10424444-HIV Infections,
pubmed-meshheading:10424444-HIV-1,
pubmed-meshheading:10424444-Humans,
pubmed-meshheading:10424444-Interleukin-15,
pubmed-meshheading:10424444-Killer Cells, Natural,
pubmed-meshheading:10424444-Lectins, C-Type,
pubmed-meshheading:10424444-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:10424444-Receptors, IgG,
pubmed-meshheading:10424444-T-Lymphocyte Subsets
|
pubmed:year |
1999
|
pubmed:articleTitle |
Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15.
|
pubmed:affiliation |
Unité d'Oncologie Virale and URA CNRS 1930, Département SIDA et Rétrovirus, Institut Pasteur, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|